Ignite Creation Date:
2024-07-17 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06491992
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-07-01
Brief Title:
Chitosan Phonophresis on Cervical IN Smartphone Addicted Users
Sponsor:
October 6 University
Organization:
October 6 University
Study Overview
Official Title:
Effect of Chitosan Phonophresis on Cervical Pain and Disability in Smartphone Addicted Users
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A phonophoresis-based drug delivery system is a synchronous approach to improve local drug penetration in neuromuscular diseases associated with neuronal damage excruciating pain and local inflammation Chitosan a semi-synthetic material is obtained by partial deacetylation of chitin amines resulting in copolymers of N-acetylglucosamine and N-glucosamine Its use has been explored in various biomaterial and medical applications Chitosan has emerged as a cost-effective biocompatible and biodegradable material with many desirable biological properties improvement of homeostasis and antiviral potential Chitosan was found to suppress pro-inflammatory cytokines and decreased peripheral nerve edema the polycationic nature of chitosan allows it to absorb protons which reduces inflammation and provides an analgesic effect
Detailed Description:
The patients will randomly be divided into two equal groups the control group which will receive the selected exercise program and the study group will receive the same exercise training program in addition to Chitosan Phonophresis three times per week for four weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None